BSE - Delayed Quote INR

Krsnaa Diagnostics Limited (KRSNAA.BO)

641.10
+4.25
+(0.67%)
At close: May 30 at 3:29:38 PM GMT+5:30
Loading Chart for KRSNAA.BO
  • Previous Close 636.85
  • Open 640.95
  • Bid 638.00 x --
  • Ask 641.00 x --
  • Day's Range 628.00 - 643.50
  • 52 Week Range 527.55 - 1,041.80
  • Volume 9,492
  • Avg. Volume 6,631
  • Market Cap (intraday) 20.701B
  • Beta (5Y Monthly) -0.20
  • PE Ratio (TTM) 27.25
  • EPS (TTM) 23.53
  • Earnings Date --
  • Forward Dividend & Yield 2.50 (0.39%)
  • Ex-Dividend Date Sep 13, 2024
  • 1y Target Est 1,078.50

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.

krsnaadiagnostics.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: KRSNAA.BO

View More

Performance Overview: KRSNAA.BO

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

KRSNAA.BO
27.46%
S&P BSE SENSEX (^BSESN)
4.24%

1-Year Return

KRSNAA.BO
11.26%
S&P BSE SENSEX (^BSESN)
10.24%

3-Year Return

KRSNAA.BO
19.47%
S&P BSE SENSEX (^BSESN)
45.64%

5-Year Return

KRSNAA.BO
37.45%
S&P BSE SENSEX (^BSESN)
151.21%

Compare To: KRSNAA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KRSNAA.BO

View More

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    20.65B

  • Enterprise Value

    21.72B

  • Trailing P/E

    27.14

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.94

  • Price/Book (mrq)

    2.34

  • Enterprise Value/Revenue

    3.03

  • Enterprise Value/EBITDA

    10.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.82%

  • Return on Assets (ttm)

    5.19%

  • Return on Equity (ttm)

    9.17%

  • Revenue (ttm)

    7.17B

  • Net Income Avi to Common (ttm)

    776.08M

  • Diluted EPS (ttm)

    23.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    684.36M

  • Total Debt/Equity (mrq)

    23.06%

  • Levered Free Cash Flow (ttm)

    210.21M

Research Analysis: KRSNAA.BO

View More

Company Insights: KRSNAA.BO

Research Reports: KRSNAA.BO

View More

People Also Watch